Literature DB >> 7524346

Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion.

T W Gauthier1, K L Davenpeck, A M Lefer.   

Abstract

We studied the effects of exogenous nitric oxide (NO) on leukocyte-endothelial interaction after 60 min of splanchnic artery ischemia and 120 min of reperfusion (SAO/R) in pentobarbital sodium-anesthetized rats via intravital microscopy. Treatment with the NO donor S-nitroso-N-acetylpenicillamine (SNAP, 20 micrograms/kg bolus followed by infusion at 20 micrograms.kg-1.h-1), beginning 10 min before reperfusion, resulted in significantly decreased leukocyte-endothelial interaction. This was manifested by a significant decrease in leukocyte rolling and adherence in the postcapillary venules. Tissue protection was demonstrated by a significantly lower plasma free amino-nitrogen concentration in the SNAP-treated SAO/R rats compared with those receiving NO-depleted SNAP (P < 0.05). Immunohistochemical localization of P-selectin showed significantly decreased P-selectin expression on the venular endothelium after SAO/R in rats given SNAP 10 min before reperfusion (23.0 +/- 3.2% vs. 54.9 +/- 12.1% positive staining, respectively, P < 0.01). From these data, we conclude that the effects of exogenous NO on leukocyte-endothelial interaction after ischemia-reperfusion appear to be at least partially mediated through the endothelial adhesion molecule P-selectin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524346     DOI: 10.1152/ajpgi.1994.267.4.G562

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  34 in total

1.  Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats.

Authors:  D J Lefer; R Scalia; B Campbell; T Nossuli; R Hayward; M Salamon; J Grayson; A M Lefer
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds.

Authors:  A Fox-Robichaud; D Payne; S U Hasan; L Ostrovsky; T Fairhead; P Reinhardt; P Kubes
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

Review 3.  Selectin-carbohydrate interactions during inflammation and metastasis.

Authors:  R P McEver
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion.

Authors:  S Cuzzocrea; E Mazzon; L Dugo; A P Caputi; K Aston; D P Riley; D Salvemini
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid.

Authors:  T J Stalker; A M Lefer; R Scalia
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

Review 6.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion.

Authors:  M Buerke; T Murohara; C Skurk; C Nuss; K Tomaselli; A M Lefer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat.

Authors:  Stefania Marzocco; Emanuela Mazzon; Aldo Pinto; Giuseppina Autore; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-17       Impact factor: 3.000

9.  Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass.

Authors:  M Chello; P Mastroroberto; G Patti; A D'Ambrosio; M Cortez Morichetti; G Di Sciascio; E Covino
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

10.  Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice.

Authors:  Hal X Nguyen; James G Tidball
Journal:  J Physiol       Date:  2003-05-23       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.